Yoriaki Komeda Selected Research

Disease Progression

1/2018	Sustained antiviral effects and clearance of hepatitis surface antigen after combination therapy with entecavir and pegylated interferon in chronic hepatitis B.
1/2017	Stress Response Protein RBM3 Promotes the Development of Colitis-associated Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoriaki Komeda Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 01/2017
5	Ulcerative Colitis 12/2020 - 01/2017
4	Polyps 11/2022 - 01/2017
4	Hemorrhage 01/2021 - 11/2005
3	Chronic Hepatitis B 09/2022 - 01/2018
3	Crohn Disease (Crohn's Disease) 04/2021 - 01/2017
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 03/2018
3	Carcinogenesis 01/2019 - 01/2017
2	Inflammation (Inflammations) 07/2021 - 01/2017
2	Pathologic Constriction (Stenosis) 07/2021 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 08/2020 - 06/2017
2	Varicose Veins (Varicose Vein) 01/2020 - 11/2005
2	Infections 08/2019 - 01/2017
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2019 - 03/2018
2	Disease Progression 01/2018 - 01/2017
2	Colitis-Associated Neoplasms 04/2017 - 01/2017
2	Liver Diseases (Liver Disease) 01/2017 - 01/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 01/2016
2	Ascites 01/2016 - 01/2016
1	Pain (Aches) 07/2022
1	Adenoma (Adenomas) 01/2022
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 07/2021
1	Vasculitis (Vasculitides) 07/2021
1	Deglutition Disorders (Dysphagia) 07/2021
1	Hypersensitivity (Allergy) 07/2021
1	Thromboembolism 01/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2020
1	Ulcer 08/2020
1	Enteritis 07/2020
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 07/2020
1	Diarrhea 08/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2019
1	Adenocarcinoma 05/2019
1	Sclerosing Cholangitis 05/2019
1	Stomach Neoplasms (Stomach Cancer) 05/2019
1	Colitis 01/2019
1	Thymoma (Thymic Carcinoma) 01/2019
1	Pancytopenia 03/2018

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 04/2021 - 01/2017
3	Immune Checkpoint InhibitorsIBA 09/2022 - 08/2020
3	AnticoagulantsIBA 01/2021 - 01/2017
3	Antiviral Agents (Antivirals)IBA 10/2019 - 01/2017
2	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2021 - 01/2021
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021 - 01/2019
2	Autophagy-Related ProteinsIBA 01/2021 - 08/2020
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 01/2019
2	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 08/2020 - 01/2017
2	entecavir FDA Link 10/2019 - 01/2018
2	Interleukin-17 (Interleukin 17)IBA 03/2018 - 01/2017
2	InterferonsIBA 01/2018 - 01/2017
2	thiamine triphosphorate (TTP)IBA 06/2017 - 01/2017
2	Furosemide (Lasix)FDA LinkGeneric 01/2016 - 01/2016
2	Tolvaptan FDA Link 01/2016 - 01/2016
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2022
1	SolutionsIBA 01/2022
1	Myeloblastin (Proteinase 3)IBA 07/2021
1	Metoclopramide (Reglan)FDA LinkGeneric 07/2021
1	Castor Oil (Oil, Castor)IBA 07/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 07/2021
1	magnesium citrateIBA 07/2021
1	LigandsIBA 04/2021
1	NucleotidesIBA 01/2021
1	tofacitinibIBA 12/2020
1	Janus Kinase InhibitorsIBA 12/2020
1	Inosine Triphosphate (ITP)IBA 12/2020
1	Adalimumab (Humira)FDA Link 11/2020
1	Mesalamine (Mesalazine)FDA LinkGeneric 11/2020
1	Keratin-19 (Keratin 19)IBA 08/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2020
1	GlucocorticoidsIBA 07/2020
1	Prednisolone (Predate)FDA LinkGeneric 07/2020
1	tenofovir alafenamideIBA 10/2019
1	Azathioprine (Imuran)FDA LinkGeneric 08/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2019
1	secukinumabIBA 08/2019
1	Ustekinumab (CNTO 1275)FDA Link 07/2019
1	NivolumabIBA 05/2019
1	130-nm albumin-bound paclitaxelIBA 05/2019
1	RamucirumabIBA 05/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Sulfonic AcidsIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2019
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2019
1	Dextrans (Dextran)FDA Link 01/2019
1	Azacitidine (5 Azacytidine)FDA Link 03/2018

Therapy/Procedure

15	Therapeutics 01/2021 - 01/2016
2	Sclerotherapy 01/2020 - 11/2005
2	Drug Therapy (Chemotherapy) 05/2019 - 01/2019
2	Endoscopic Hemostasis 01/2019 - 01/2017
1	Lasers (Laser) 11/2022
1	Colonoscopes 07/2022
1	Length of Stay 01/2021
1	Bridge Therapy 01/2021
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Jejunostomy 01/2020
1	Immunotherapy 05/2019
1	Rectal Administration 01/2019